We are live on ! Find out more

SLSN

Solesence Inc

SLSN

Market cap $64.3M

Positive

Neutral

Negative

Sentiment 3-Months

Positive 10%

Neutral 90%

Negative 0%

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

ROMEOVILLE, Ill., July 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the second quarter of 2026 before the market opens on Tuesday, August 11, 2026, and host a conference call and webcast on the same date.

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

Zacks Investment Research

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.

SLSN Unveils Two Scalp Care Products Using Patented Technology

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

New White Label Collection, Powered by WHSPR™ and Kleair™, Debuts with Revitalizing Scalp Serum and Scalp Screen Dry Shampoo SPF 45+ Sunscreen

Solésence Brings Patent-Backed Skin Health Innovation to Hair and Scalp

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.

Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

SPF-Infused Concealer Featuring Kleair™, WHSPR™, and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin

Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition

Zacks Investment Research

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.

SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

The report, led by the United Kingdom's APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation.

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solésence Reports First Quarter 2026 Financial Results

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026.

Solésence Reports First Quarter 2026 Financial Results

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment

Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™

See News Rankings